Editorial Board

5 Editors in 4 Countries/Regions

Italy (2)
China (1)
Germany (1)
United States (1)

Editor-in-Chief

Ralf Weiskirchen

rweiskirchen@ukaachen.de

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany.

Research Interests: TGF-beta, PDGF, liver, fibrosis, extracellular matrix

Special Issue:

Genetic and Epigenetic Factors in Liver Disease Pathogenesis

Metabolic Mysteries: The Role of Copper Dysregulation in Liver Disease

Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Associate Editors

Guoxun Chen

College of Food Science and Technology, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan, China.

Research Interests: hepatic gene expression, nutrient regulation, Vitamin A, insulin resistance, obesity,Type 2 diabetes

Sharmila Fagoonee

post-transcriptional pegulation of gene expression, cell biology, extracellular vesicles, RNA-binding proteins

Research Interests: post-transcriptional pegulation of gene expression, cell biology, extracellular vesicles, RNA-binding proteins

Gabriele Grassi

Clinical Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, Trieste University, Trieste, Italy.

Research Interests: cancer, MiRNA, Mechanism of drug action, hepatocellular carcinoma (HCC) , siRNA delivery, development of monitoring tests for lung functions

Editorial Board Members

Kisseleva Tatiana

Department of Surgery, University of California, San Diego, La Jolla, USA.

Research Interests: liver fibrosis, MASLD, inflammation

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.